Latitude Pharmaceuticals, Inc.
Date of Award
12.03.2012
Program
Type 1 Diabetes, Improve Outcomes
Amount
$694,220
Term of Grant
43 months
Project Title
Stabilized Glucagon Formulations
12.03.2012
Type 1 Diabetes, Improve Outcomes
$694,220
43 months
Stabilized Glucagon Formulations